RSA welcomes new starter
November 28, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Huberts, rsa
Life Sciences Executive Search and Interim Management specialists RSA, has announced that Michael Huberts has joined the UK business as …
TranslateMedia listed in the Deloitte UK Fast 50 for the third year running
November 27, 2012Medical Communications
International translation and transcreation agency, TranslateMedia has been listed in the Deloitte UK Fast 50 for the third consecutive year, …
EMA’s five points on data release
November 27, 2012Medical Communications, Research and Development, Sales and Marketing EFPIA, EMA, Rasi, transparency
The European Medicines Agency has highlighted five areas that need to be ironed out before it begins publishing clinical trial …
‘Adopt NICE decisions’ committee told
November 27, 2012Sales and Marketing ABPI, Dorrell, NHS, NICE, Whitehead
ABPI chief executive Stephen Whitehead has again urged the NHS to adopt and use the drugs which NICE approves, and …
Targacept confirms Stephen Hill as president and chief executive
November 27, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Targacept, stephen hill
Clinical-stage biopharma firm Targacept has announced that Stephen Hill has been appointed as president and chief executive. Hill is expected …
Glass particles force recall of Ranbaxy Lipitor
November 27, 2012Manufacturing and Production, Sales and Marketing Daiichi Sankyo, Lipitor, Pfizer, Ranbaxy, recall
Ranbaxy Pharmaceuticals is recalling around 40 batches of its generic atorvastatin tablets after discovering that some of the product may …
UCB sells Indian production plant to Exemed
November 27, 2012Manufacturing and Production API, Exemed, UCB, vapi
UCB Pharma has signed a deal to sell its manufacturing facility in Vapi, India, to local firm Exemed Pharmaceuticals. The …
MPs pharma investigation in offing
November 26, 2012Sales and Marketing ABPI, Bad pharma, M&P, MP, NICE, trial data
A health select committee inquiry into pharma companies withholding clinical trial data is being considered, according to committee chair Stephen …
Summit appoints two non-executive directors
November 26, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Frank Armstrong, Jim Mellon, summit
UK drug discovery and development firm Summit has appointed Jim Mellon and Dr Frank Armstrong as non-executive directors. The additions …
Vifor ad breaches Code
November 26, 2012Sales and Marketing ABPI, PMCPA, Vifor, ferinject
Vifor has been blasted after failing to adhere to an earlier ruling made under the ABPI’s Code of Practice. Such …
Roche to release Tamiflu data
November 23, 2012Sales and Marketing BMJ, Cochrane, Goldacre, NHS, Roche, Tamiflu
Roche has said it will let researchers have access to more data on its influenza vaccine Tamiflu, apparently under pressure …
Burson-Marsteller appoints Kate Hawker as MD and chair
November 23, 2012Medical Communications, Sales and Marketing Burson-Marsteller
PR firm Burson-Marsteller has hired pharma comms expert Kate Hawker as managing director and chair of both its EMEA and …
NICE medicines uptake dissected
November 23, 2012Sales and Marketing HSCIC, IMS, NICE
Lack of diagnosis, ignoring required tests, muddled commissioning and local policy variations are among the key reasons why NICE-approved drugs …
GSK’s Promacta extends US licence
November 22, 2012Sales and Marketing FDA, GSK, Promacta, Revolade
GlaxoSmithKline’s Promacta has received a new indication from the FDA which means it can be used for patients with thrombocytopenia …
Further indications for Eliquis
November 22, 2012Sales and Marketing BMS, Eliquis, NVAF, Pfizer, Pradaxa, Xarelto
Bristol-Myers Squibb and Pfizer’s oral blood-thinner Eliquis has been approved in Europe to prevent stroke in patients with nonvalvular atrial …
Jim Easton steps down from NHS Commissioning Board role
November 22, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Easton, NHS, NHS Commissioning Board
Jim Easton has stepped down from his role as national director: Transformation at the NHS Commissioning Board (CB) and his …
New NHS, new customers – tips from the frontline
November 21, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CCGs, Commissioning Board, Dixon, NHS, Sobanja, pharmafile
In the noisy and continuing debate over health reform, it is worth remembering the aim of the coalition government’s health …
Xarelto gets new EU approval
November 21, 2012Sales and Marketing AF, Bayer, DVT, Xarelto
Bayer’s oral anticoagulant Xarelto has extended its licence in Europe to treat pulmonary embolism (PE) and prevent recurrent deep vein …
Almirall appoints first woman to its Board
November 21, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Almirall
Karin Louise Dorrepaal is the first woman to join Almirall’s ten-member Board of directors. Dorrepaal, who is Dutch, has extensive …
Pfizer in cystic fibrosis alliance
November 21, 2012Research and Development, Sales and Marketing CFFT, CFTR, FDA, Pfizer
Pfizer and Cystic Fibrosis Foundation Therapeutics (CFFT) have signed a six-year pre-clinical deal to find new drugs to treat the …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
